Regeneron seeks injunction against Amgen in US antitrust case over cholesterol drug
MLex Summary: Regeneron asked a US judge to enter a permanent injunction against Amgen regarding cholesterol-reducing medication. Regeneron asked the court to prohibit Amgen from engaging in cross-therapeutic bundling through the...To view the full article, register now.
Already a subscriber? Click here to view full article